Amphastar Pharmaceuticals, Inc banner

Multiples-Based Value

The Multiples-Based Value for Amphastar Pharmaceuticals, Inc (29A) under the Base Case is 33.86 EUR. Compared with the current market price of 22.82 EUR, the stock appears Undervalued by 33% .

Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

29A Multiples-Based Value
Base Case
€33.86
Undervaluation 33%
Multiples-Based Value
Price €22.82

Multiples Across Competitors

29A Competitors Multiples
Amphastar Pharmaceuticals, Inc Competitors